Related Experiment Video
Updated: Jan 20, 2026

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
Published on: May 29, 2014
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Silvia Schmidtova1, Katarina Kalavska2,3,4, Katarina Gercakova2
1Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. silvia.schmidtova@savba.sk.
Abstract:
Cisplatin resistance in testicular germ cell tumors (TGCTs) is a clinical challenge. We investigated the underlying mechanisms associated with cancer stem cell (CSC) markers and modalities circumventing the chemoresistance. Chemoresistant models (designated as CisR) of human embryonal carcinoma cell lines NTERA-2 and NCCIT were derived and characterized using flow cytometry, gene expression, functional and protein arrays. Tumorigenicity was determined on immunodeficient mouse model. Disulfiram was used to examine chemosensitization of resistant cells. ALDH1A3 isoform expression was evaluated by immunohistochemistry in 216 patients' tissue samples. Chemoresistant cells were significantly more resistant to cisplatin, carboplatin and oxaliplatin compared to parental cells. NTERA-2 CisR cells exhibited altered morphology and increased tumorigenicity. High ALDH1A3 expression and increased ALDH activity were detected in both refractory cell lines. Disulfiram in combination with cisplatin showed synergy for NTERA-2 CisR and NCCIT CisR cells and inhibited growth of NTERA-2 CisR xenografts. Significantly higher ALDH1A3 expression was detected in TGCTs patients' tissue samples compared to normal testicular tissue. We characterized novel clinically relevant model of chemoresistant TGCTs, for the first time identified the ALDH1A3 as a therapeutic target in TGCTs and more importantly, showed that disulfiram represents a viable treatment option for refractory TGCTs.
Insights
Cisplatin resistance in testicular germ cell tumors is a challenge. Researchers identified ALDH1A3 as a therapeutic target and found disulfiram effective in overcoming chemoresistance in these cancers.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Cisplatin resistance presents a significant clinical challenge in treating testicular germ cell tumors (TGCTs).
- Cancer stem cell (CSC) markers are implicated in chemoresistance, necessitating investigation into novel therapeutic strategies.
- Understanding the mechanisms of chemoresistance is crucial for developing effective treatments for refractory TGCTs.
Purpose of the Study:
- To investigate mechanisms of cisplatin resistance in TGCTs, focusing on cancer stem cell markers.
- To identify potential therapeutic targets and modalities to overcome chemoresistance in TGCTs.
- To evaluate disulfiram as a chemosensitizing agent in cisplatin-resistant TGCT models.
Main Methods:
- Development and characterization of cisplatin-resistant (CisR) TGCT cell lines (NTERA-2, NCCIT) using flow cytometry, gene expression, and protein arrays.
- Assessment of tumorigenicity in immunodeficient mouse models.
- Evaluation of ALDH1A3 expression via immunohistochemistry in 216 patient samples and in vitro assays.
- Testing the synergistic effect of disulfiram and cisplatin on resistant cells and xenografts.
Main Results:
- CisR cells exhibited significantly increased resistance to platinum-based chemotherapeutics (cisplatin, carboplatin, oxaliplatin).
- NTERA-2 CisR cells showed altered morphology, increased tumorigenicity, high ALDH1A3 expression, and elevated ALDH activity.
- Disulfiram combined with cisplatin demonstrated synergistic effects in resistant cell lines and inhibited xenograft growth.
- Elevated ALDH1A3 expression was observed in TGCT patient tissues compared to normal testicular tissue.
Conclusions:
- A novel, clinically relevant model of chemoresistant TGCTs was characterized.
- ALDH1A3 was identified as a potential therapeutic target for overcoming cisplatin resistance in TGCTs.
- Disulfiram represents a promising treatment option for patients with refractory TGCTs, particularly in combination with cisplatin.
Related Concept Videos
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...

